Type beta transforming growth factor in human platelets: release during platelet degranulation and action on vascular smooth muscle cells.
about
Platelet effects on ovarian cancerHealing of burn wounds in transgenic mice overexpressing transforming growth factor-beta 1 in the epidermisEndoplasmic reticulum thiol oxidase deficiency leads to ascorbic acid depletion and noncanonical scurvy in micePositive- and negative-acting Kruppel-like transcription factors bind a transforming growth factor beta control element required for expression of the smooth muscle cell differentiation marker SM22alpha in vivo.Cell cycle versus density dependence of smooth muscle alpha actin expression in cultured rat aortic smooth muscle cells.TGF-beta promotes proliferation of cultured SMC via both PDGF-AA-dependent and PDGF-AA-independent mechanisms.Transforming growth factor-Beta binds reversibly in vitro to guglielmi detachable coils.Transforming growth factor-beta-induced growth inhibition and cellular hypertrophy in cultured vascular smooth muscle cells.Vessel wall BAMBI contributes to hemostasis and thrombus stability.In vitro and in vivo evidence that thrombospondin-1 (TSP-1) contributes to stirring- and shear-dependent activation of platelet-derived TGF-beta1.Transforming growth factor beta increases mRNA for matrix proteins both in the presence and in the absence of changes in mRNA stability.Transforming growth factor beta stimulates collagen-matrix contraction by fibroblasts: implications for wound healing.Current therapies for wound healing: electrical stimulation, biological therapeutics, and the potential for gene therapy.Rapamune does not attenuate high cholesterol-induced atherosclerosis in rabbits.Growth factors in wound healing. Single and synergistic effects on partial thickness porcine skin wounds.An activated form of transforming growth factor beta is produced by cocultures of endothelial cells and pericytes.In vivo engineering of organs: the bone bioreactor.Targeting expression of a transforming growth factor beta 1 transgene to the pregnant mammary gland inhibits alveolar development and lactation.Macrophage LRP1 suppresses neo-intima formation during vascular remodeling by modulating the TGF-β signaling pathway.Antibodies against transforming growth factor-beta 1 suppress intimal hyperplasia in a rat model.Production of transforming growth factor beta 1 during repair of arterial injury.Transforming growth factor-beta activity in sheep lung lymph during the development of pulmonary hypertensionTransforming growth factor type beta specifically stimulates synthesis of proteoglycan in human adult arterial smooth muscle cellsInhibitory action of transforming growth factor beta on endothelial cells.Transforming growth factor type beta induces monocyte chemotaxis and growth factor production.Expression and secretion of type beta transforming growth factor by activated human macrophages.Transforming growth factor-beta. Murine glomerular receptors and responses of isolated glomerular cells.Insulin-like synergistic stimulation of DNA synthesis in Swiss 3T3 cells by the BSC-1 cell-derived growth inhibitor related to transforming growth factor type betaPerlecan regulates Oct-1 gene expression in vascular smooth muscle cells.Expression of COX-2 in platelet-monocyte interactions occurs via combinatorial regulation involving adhesion and cytokine signalingTransforming growth factor β inhibits platelet derived growth factor-induced vascular smooth muscle cell proliferation via Akt-independent, Smad-mediated cyclin D1 downregulationDifferentiation between benign and malignant ovarian masses in the preoperative period using neutrophil-to-lymphocyte and platelet-to-lymphocyte ratiosTransforming growth factor-beta in disease: the dark side of tissue repair.Vascular smooth muscle cell hypertrophy vs. hyperplasia. Autocrine transforming growth factor-beta 1 expression determines growth response to angiotensin II.Regulation of smooth muscle cell growth by endothelium-derived factors.Blood Plasma TGF- β1 Concentration in Sporadic Dilatative Pathology of Ascending Aorta: More Questions than AnswersExtracellular matrix proteins in hemostasis and thrombosisDecreased type II/type I TGF-beta receptor ratio in cells derived from human atherosclerotic lesions. Conversion from an antiproliferative to profibrotic response to TGF-beta1.Transforming growth factor-beta initiates wound repair in rat liver through induction of the EIIIA-fibronectin splice isoform.Derivation and properties of platelet-derived growth factor-independent rat smooth muscle cells.
P2860
Q26829401-C08A57D6-5518-4473-A323-1847298C17FEQ28365742-4CF54D2B-275F-4DD3-A8A6-C934BC680C87Q28508619-999A807E-0456-4E0D-8E9F-3E3CAA6A381FQ30305991-0EDE1F92-B40C-4E37-8D8A-38C0C2CFEB5FQ30442323-3A8A3380-F726-4FFC-B356-56403AC5D20CQ30449271-95987C9B-D405-4B53-9788-BEE0EFA3C688Q30451464-31117251-B29F-4268-A76C-D34C0374AAC9Q30461802-B0500B8C-8FFD-4F3D-9226-F46A0632ACCDQ30577434-10349096-FAC6-44ED-B940-032254703BCAQ33492753-C82EF7D7-7304-41DD-A191-1C76183306DDQ33553280-E8213584-2FB2-46C4-8A92-F4FCD17DF8FAQ33586426-54D82FC8-75E7-491E-96AB-DA4194CEF664Q33785792-7B8085E6-124C-4BE1-8864-DD8F1F250EEAQ33848041-A55D8D43-C61D-4D56-930C-1B5B4004B569Q33848658-6D97953E-8918-4275-BAAC-F348302B1B4DQ33862469-9E0607D6-7D27-4CE5-B5E6-E092BF43D641Q33914089-765891D4-7944-4270-8167-BBD10C1AD381Q34050002-640921C4-77EB-4803-B1FB-31A31DE742E2Q34103433-FDDBA36B-8AC0-4F18-9F6A-B38151B544E5Q34133039-87DB5687-1EC9-4F24-A38D-B259A7EA507CQ34198234-9A54FBD4-91F5-4152-86AA-CE619C9CD750Q34262965-93D4DC3C-A69A-497B-90F4-CB8DBFFA2AD2Q34333889-3DB7D234-D3A7-4B29-8CAB-FF8779827CDCQ34337298-E35D77B5-4CB3-4FB4-9C57-34627EAF77ACQ34339289-EC0D9E28-2223-4B06-8B3E-2BE6C10B6880Q34341606-3C200545-7503-4788-9625-FA54DED421FCQ34570091-8274AC3D-38F0-4B36-8CE8-63FAC60CB004Q34627626-0AA3AEBD-ACAA-400B-95AC-C5F3C38A124FQ34670208-4D8A13BE-D67C-4C3F-8D6F-C20622200D4CQ35039893-878CE6C7-77AD-4000-B841-E1F40B975C01Q35043874-3503AA88-CBF2-4FB9-84AB-7D1F8E1691EBQ35180082-C1D59980-37EE-44D7-8F54-59DD8391ACCEQ35603155-178ABBFE-7AD1-4452-A61A-3E53D0C88120Q35605118-94E97C8B-FC48-4B3B-B3E3-8C8CB698AE0BQ35652173-798798CB-C75C-4C51-A828-41DCD24BA282Q35672066-8DD8EE1D-C1AA-41C6-ADB9-DD18556191FCQ35762807-C24E63A3-EE43-4288-928F-8A7B8FB00DCCQ35767892-96828F65-F124-4858-BEA1-811CF5D9174EQ35793352-FB2012A4-B3FB-4F1A-BB71-D2274FE73D36Q35811693-33475A4D-D15A-444E-A331-BED8856470CF
P2860
Type beta transforming growth factor in human platelets: release during platelet degranulation and action on vascular smooth muscle cells.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
1986年论文
@zh
1986年论文
@zh-cn
name
Type beta transforming growth ...... vascular smooth muscle cells.
@ast
Type beta transforming growth ...... vascular smooth muscle cells.
@en
type
label
Type beta transforming growth ...... vascular smooth muscle cells.
@ast
Type beta transforming growth ...... vascular smooth muscle cells.
@en
prefLabel
Type beta transforming growth ...... vascular smooth muscle cells.
@ast
Type beta transforming growth ...... vascular smooth muscle cells.
@en
P2860
P356
P1476
Type beta transforming growth ...... vascular smooth muscle cells.
@en
P2093
P2860
P304
P356
10.1083/JCB.102.4.1217
P407
P577
1986-04-01T00:00:00Z